Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer

NCT04178174 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

360

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Oropharynx Cancer
Human Papilloma Virus

Interventions

RADIATION: SABR boost and de-escalated chemoradiation
RADIATION: Standard chemoradiation

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Collaborators

[object Object]
[object Object]
[object Object]